Weight Loss Drugs News
Major board shake-up at Novo Nordisk amid leadership clash
The Guardian - 21-Oct-2025
Wegovy maker faces leadership overhaul after dispute with its largest shareholder
Read more...Biohacker Bryan Johnson halts weight-loss drug experiment over side effects
UNILAD - 09-Oct-2025
Microdosing tirzepatide raised heart rate and lowered sleep quality for the longevity enthusiast
Read more...Weight loss drugs may cut hospital visits and deaths in heart patients
The Guardian - 31-Aug-2025
These drugs could provide a powerful new option for millions worldwide
Read more...New obesity pill shows 12% weight loss in trials
BBC - 08-Aug-2025
Orforglipron offers a needle-free option for tackling obesity, pending global approval
Read more...GLP-1 drug semaglutide linked to significant age reversal in study
Futurism - 08-Aug-2025
Semaglutide study reveals slowed aging in key organs and up to five years’ brain age reversal
Read more...The future of weight loss might be one injection away
Live Forever Club - 18-Jul-2025
This may be a way to treat lifestyle diseases at the root, biologically and sustainably
Read more...Clearing senescent cells may treat obesity-linked diabetes and organ damage
Live Forever Club - 15-Jul-2025
Removing these aged cells may improve organ function
Read more...New fat-burning pill offers alternative to weight-loss injections
Independent - 24-Jun-2025
Fat-burning pill preserves appetite and muscle; safe in early trials
Read more...Diabetes and weight loss drugs may raise risk of eye damage in older patients
The Guardian - 05-Jun-2025
Study links GLP-1 drugs to higher risk of macular degeneration in diabetics over 60
Read more...Mounjaro outperforms Wegovy in landmark weight-loss trial
BBC - 12-May-2025
Trial reveals key differences in how leading obesity drugs perform and what they offer patients
Read more...Weight-loss drug semaglutide shows promise in reducing alcohol consumption
The Guardian - 12-Feb-2025
Early clinical trial finds the medication curbs cravings and cuts heavy drinking
Read more...Drugs like Ozempic and Wegovy lower risks for 42 conditions but increase risks for 19 others
New Scientist - 20-Jan-2025
Approved uses are beneficial, but risks for off-label uses remain uncertain
Read more...Obesity rates drop in the U.S. for the first time in a decade
Independent - 13-Dec-2024
New research links weight-loss drugs to regional trends and health shifts
Read more...BioAge halts obesity drug trial after safety concerns
BioPharma Dive - 07-Dec-2024
Liver enzyme spikes in participants prompt a major setback for the biotech firm
Read more...Diabetes drugs show promise in protecting kidneys
Independent - 26-Nov-2024
Life-saving kidney and heart benefits found in non-diabetic patients
Read more...Ozempic shows promise beyond diabetes and weight loss
BBC - 15-Oct-2024
Large trial links semaglutide to lower death rates and reduced inflammation in heart patients
Read more...Semaglutide may dampen motivation to exercise in mice
New Scientist - 09-Oct-2024
Findings highlight potential unintended effects of weight-loss medications on exercise motivation
Read more...Bioage prepares for IPO, targets obesity with new drug trials
FierceBiotech - 04-Sep-2024
Biotech firm Bioage plans public debut as it advances promising obesity treatments
Read more...MHRA has approved Mounjaro, a diabetes drug that promotes weight loss
GOV.UK - 08-Nov-2023
The drug works by regulating appetite and reducing cravings
Read more...Weight loss jab is now approved for NHS use in England
BBC - 08-May-2023
Semaglutide tricks your stomach to feel fuller and more satisfied; may be ineffective after withdrawl
Read more...A Diabetes drug brings dramatic weight loss in obese patients
BBC - 11-Feb-2021
Semaglutide suppresses appetite, helping trail participants lose 20% of their weight
Read more...
